Advertisement

Advertisement

LGND Stock Latest News

Ligand price target raised to $266 from $263 at BofA

The FlyLigand price target raised to $266 from $263 at BofA

Ligand Pharmaceuticals Bets Big on Royalty Growth

PremiumCompany Announcements

Ligand Pharmaceuticals Bets Big on Royalty Growth

15d ago

Ligand Pharma Advances XOMA Royalty Acquisition with Amendment

PremiumCompany Announcements

Ligand Pharma Advances XOMA Royalty Acquisition with Amendment

17d ago

Ligand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push

PremiumCompany Announcements

Ligand Pharmaceuticals’ Earnings Call Signals Scaled Royalty Push

23d ago

Ligand reports Q1 adjusted EPS $1.63, consensus $1.80

PremiumThe Fly

Ligand reports Q1 adjusted EPS $1.63, consensus $1.80

28d ago

Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21

PremiumThe FlyLigand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21

28d ago

Orchestra BioMed receives $15M payment from Ligand

The Fly

Orchestra BioMed receives $15M payment from Ligand

28d ago

LGND Earnings this Week: How Will it Perform?

Pre-Earnings

LGND Earnings this Week: How Will it Perform?

30d ago

Ligand Pharma Ends TR‑Beta License With Viking Therapeutics

PremiumCompany Announcements

Ligand Pharma Ends TR‑Beta License With Viking Therapeutics

1M ago

Ligand price target raised to $289 from $243 at H.C. Wainwright

PremiumThe Fly

Ligand price target raised to $289 from $243 at H.C. Wainwright

1M ago

Ligand price target raised to $252 from $235 at RBC Capital

PremiumThe Fly

Ligand price target raised to $252 from $235 at RBC Capital

1M ago

Analyst Reiterates Buy on Ligand, Lifts Price Target to $260 on Royalty Portfolio Expansion from XOMA Acquisition

PremiumRatings

Analyst Reiterates Buy on Ligand, Lifts Price Target to $260 on Royalty Portfolio Expansion from XOMA Acquisition

1M ago

Ligand price target raised to $255 from $230 at Stifel

PremiumThe FlyLigand price target raised to $255 from $230 at Stifel

1M ago

Ligand price target raised to $260 from $250 at BofA

The Fly

Ligand price target raised to $260 from $250 at BofA

1M ago

Ligand Pharma to Acquire XOMA, Expands Royalty Portfolio

Company Announcements

Ligand Pharma to Acquire XOMA, Expands Royalty Portfolio

1M ago

Morning Movers: Domino’s Pizza sinks following first quarter results

PremiumThe Fly

Morning Movers: Domino’s Pizza sinks following first quarter results

1M ago

Ligand to acquire Xoma for $39.00 per share in cash

PremiumThe Fly

Ligand to acquire Xoma for $39.00 per share in cash

1M ago

Ligand to buy Xoma for $39 per share, WSJ reports

PremiumThe Fly

Ligand to buy Xoma for $39 per share, WSJ reports

1M ago

Ligand price target raised to $282 from $276 at Citi

PremiumThe Fly

Ligand price target raised to $282 from $276 at Citi

2M ago

Ligand price target raised to $243 from $239 at H.C. Wainwright

PremiumThe FlyLigand price target raised to $243 from $239 at H.C. Wainwright

2M ago

This Is Why Travere Therapeutics Stock (TVTX) Surged Today

Market News

This Is Why Travere Therapeutics Stock (TVTX) Surged Today

2M ago

Ligand price target raised to $250 from $244 at BofA

The Fly

Ligand price target raised to $250 from $244 at BofA

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >